Incidence of hypokalaemia in tazobactam/piperacillin-treated patients and identification of risk factors: a retrospective observational study
Monitoring serum potassium levels is recommended after treatment initiation of TAZ/PIPC therapy for patients with baseline serum potassium levels ≤3.7 mEq/L and diarrhoea.
Authors
- Kazutaka Oda (ORCID: https://orcid.org/0000-0003-0693-1896)
- Kazuharu Uchida
- Yoshihiro Nakagawa
- Katsumi Higashi
Institutions
- Kumamoto City Hospital (JP)
- Kumamoto University Hospital (JP)
- Kumamoto Orthopedic Surgery Hospital (JP)
Publication Details
- Journal
- European Journal of Hospital Pharmacy
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1136/ejhpharm-2025-004712
- Primary Topic
- Pharmacological Effects and Toxicity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00